BRIEF published on 09/24/2026 at 18:05, 3 days 22 hours ago Inoviem Scientific and DeepLife: Innovative Collaboration for IBD Artificial Intelligence Inoviem Scientific IBD DeepLife Validation On Human Tissue
BRIEF published on 08/24/2026 at 18:05, 1 month 3 days ago Aton completes the repayment of its ORAs subscribed with Iris Capital Strategic Development Funding Aton IRIS Capital ORA Reimbursement
BRIEF published on 06/25/2026 at 18:20, 3 months 2 days ago Pims Technology: Towards Optimizing Cancer Treatments Oncology Personalized Medicine PIMS Technology European Presence Therapeutic Evaluation
BRIEF published on 05/07/2026 at 10:05, 4 months 21 days ago Aton Group is organizing a webinar for shareholders and investors on May 12, 2026 Shareholders Biotechnology Webinar 2025 Results Aton Group
BRIEF published on 04/28/2026 at 18:05, 4 months 29 days ago 2025 Annual Results: Aton Group Strategic Partnerships Biotechnology Business Expansion 2025 Results Aton Group
BRIEF published on 04/23/2026 at 18:05, 5 months 4 days ago B Cell Design innovates in response to the shortage of diagnostic reagents Patented Technology In Vitro Diagnostics Monoclonal Antibodies B Cell Design Aton Group
BRIEF published on 04/01/2026 at 18:05, 5 months 26 days ago Aton Group: Towards a Reduction of Clinical Failures in Pharmaceuticals Clinical Trials Pharmaceutical R&D Aton Group Predictability
BRIEF published on 03/11/2026 at 18:35, 6 months 16 days ago Inoviem Scientific Advances Drug Development with Patient-Centric Approach Personalized Medicine Pharmaceutical Innovation Inoviem Scientific Patient-centric Drug Development Preclinical Programs
PRESS RELEASE published on 03/11/2026 at 18:30, 6 months 16 days ago ATON: UPDATE ON THE ACTIVITIES OF ITS SUBSIDIARY INOVIEM SCIENTIFIC Aton Group's subsidiary, Inoviem Scientific, transforms drug development by prioritizing patient samples & AI technology, accelerating preclinical programs with high-value translational data AI Technology Drug Development Inoviem Scientific Aton Group Patient Sample
BRIEF published on 03/11/2026 at 18:20, 6 months 16 days ago Inoviem Scientific: Advances in Pharmaceutical Development Personalized Medicine Pharmaceutical Development Translational Pharmacology Inoviem Scientific Integrated Platform
Published on 09/28/2026 at 15:00, 1 hour 40 minutes ago Vox to Acquire Silver Royalty over the Sorby Hills Project in Australia
Published on 09/28/2026 at 14:45, 1 hour 55 minutes ago Clinical Trial of the Oral Drug NV-387 to Treat Ebola Has Started Enrollment and Dosing of Patients Last Week (on or about September 23rd), Says NanoViricides
Published on 09/28/2026 at 14:30, 2 hours 10 minutes ago Drilling at Cat Creek Intersects a Copper-Molybdenum Porphyry System Visible Molybdenite-Chalcopyrite Over Significant Core Widths
Published on 09/28/2026 at 14:30, 2 hours 10 minutes ago Predictiv AI Completes United Nations Fleet Management Deployment Following Competitive Procurement Win
Published on 09/28/2026 at 14:00, 2 hours 40 minutes ago DoJ and DoW move to Support Resumption of Operations at Colosseum
Published on 09/28/2026 at 16:05, 35 minutes ago SwitchBot Launches RGBICWW Light Bars with Immersive Color, Everyday White Light, and Matter over Wi-Fi
Published on 09/28/2026 at 16:00, 40 minutes ago EQS-Adhoc: Shelly Group SE: SE 2026 A SAS has registered voluntary public tender offer
Published on 09/28/2026 at 15:45, 55 minutes ago Brooklyn Sports & Entertainment Names Alibaba Group an Official Technology and Cloud Partner of the Brooklyn Nets
Published on 09/28/2026 at 15:34, 1 hour 6 minutes ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 09/28/2026 at 08:02, 8 hours 38 minutes ago Saint-Gobain signs renewable electricity purchase agreement in the United Kingdom
Published on 09/25/2026 at 17:40, 2 days 23 hours ago Availability of the 2026 half-year financial report
Published on 09/24/2026 at 18:00, 3 days 22 hours ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
